These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10574787)

  • 1. Telomerase as a possible target for anticancer therapy.
    Autexier C
    Chem Biol; 1999 Nov; 6(11):R299-303. PubMed ID: 10574787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.
    Herbert B; Pitts AE; Baker SI; Hamilton SE; Wright WE; Shay JW; Corey DR
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14276-81. PubMed ID: 10588696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere maintenance as a target for anticancer drug discovery.
    Neidle S; Parkinson G
    Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
    Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
    Ganesan K; Xu B
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase as targets for cancer therapy.
    Zimmermann S; Martens UM
    Cell Mol Life Sci; 2007 Apr; 64(7-8):906-21. PubMed ID: 17310277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
    Maji B; Bhattacharya S
    Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human telomerase activity by peptide nucleic acids.
    Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
    Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase inhibitors for the treatment of cancer: the current perspective.
    Perry PJ; Arnold JR; Jenkins TC
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cell specific targeting of peptide nucleic acid oligomers.
    Zhang X; Simmons CG; Corey DR
    Bioorg Med Chem Lett; 2001 May; 11(10):1269-72. PubMed ID: 11392534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
    Jafri MA; Ansari SA; Alqahtani MH; Shay JW
    Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-mer photocontrolled oligonucleotide as an effective telomerase inhibitor.
    Xu Y; Ito K; Suzuki Y; Komiyama M
    J Am Chem Soc; 2010 Jan; 132(2):631-7. PubMed ID: 20014834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.